Exparel vs. ACB With Bupivacaine for ACL Reconstruction

Launched by CHILDREN'S HOSPITAL OF ORANGE COUNTY · Feb 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to help manage pain after surgery for an ACL tear, which is a common injury among young athletes. Specifically, the researchers want to see if a medication called Exparel, which is a long-lasting pain reliever, can help reduce the need for narcotics (strong pain medications) after surgery compared to a standard pain management technique called the Adductor Canal Block using Bupivacaine. Since misuse of opioid medications is a growing concern, especially in young people, finding effective alternatives is very important.

To participate in this trial, patients must be between 7 and 17 years old and scheduled for elective ACL reconstruction surgery at the Children's Hospital of Orange County. They should not have had major surgeries before and must be willing to complete all study procedures. If they join the trial, participants will receive one of the two pain management treatments and will be monitored during their recovery to see how well the pain is controlled and how much narcotic medication, if any, they need at home. This study is currently recruiting participants and aims to provide insights that could help improve pain management for young athletes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who are 7-17 years old undergoing elective ACL reconstruction/repair with American Society of Anesthesiologists (ASA) Classification 1-2 at Children's Hospital of Orange County (CHOC).
• • Provision of signed and dated informed consent form
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Surgery scheduled between the hours of 8am - 4pm
• Exclusion Criteria:
• • No prior major surgery (e.g. transplant procedures, cardiac, cranial surgeries)
• • Learning disability or developmental delay. Learning disability or developmental delay will have been assessed by an outside specialist. Diagnosis will have either been communicated to attending physician by the patient or will be located in patient's medical record. Anything that would impede survey completion.